Digital Look

Welcome to Digital Look++,
you are not logged in

Perrigo Company plc (PRGO)

$ 26.94

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-16	5,280.60	(4,848.30)	(1,848.76)¢	n/a	n/a	n/a	38.28¢	0.5%
31-Dec-17	4,946.20	280.10	84.00¢	103.8	n/a	n/a	64.00¢	0.7%
31-Dec-18	4,731.70	290.60	95.00¢	42.0	3.2	+13%	76.00¢	1.9%
31-Dec-19	4,837.40	171.00	107.00¢	48.3	3.7	+13%	82.00¢	1.6%
31-Dec-20	5,063.30	(149.40)	(119.00)¢	n/a	n/a	n/a	90.00¢	2.0%

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-24	4,622.98	493.15	217.00¢	12.4	n/a	n/a	110.00¢	0.0%
31-Dec-25	4,832.77	592.75	290.25¢	9.3	0.3	+34%	117.00¢	0.0%
31-Dec-26	5,009.53	639.97	331.33¢	8.1	0.6	+14%	126.50¢	0.0%

Perrigo to buy HRA Pharma in $2.1bn deal	08-Sep-2021	ShareCast
Starboard Value take 4.6% stake in Perrigo, urge...	12-Sep-2016	ShareCast
Perrigo tumbles as shareholders reject Mylan offer	13-Nov-2015	ShareCast

More generic rival OKd for Zocor	28-Dec-2006	Chicago Tribune
FDA clears six more companies to sell generic Zo...	28-Dec-2006	LA Times
Regulators Clear 6 More Companies to Sell Generi...	28-Dec-2006	New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.